PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Occlusal 26%w/w cutaneous solution salicylic acid

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Daktacort 2% / 1% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

Dermovate Scalp Application clobetasol propionate

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Eumovate Cream clobetasone butyrate

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Dermovate Scalp Application clobetasol propionate

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Package Leaflet: Information for the User

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Eumovate Ointment clobetasone butyrate

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

Retin-A 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Dermovate Ointment clobetasol propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

DP Fusidic Acid Cream

New Zealand Datasheet

1 What Gyno-Daktarin cream is and what it is used for

ACETOCAUSTIN 0,5 ml, Cutaneous solution

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

INFORMATION ABOUT YOUR TREATMENT

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

PATIENT INFORMATION LEAFLET. Timodine Cream

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Dermovate Ointment clobetasol propionate

O N C E A DAY. In this leaflet FOR WOMEN

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

ISOTREX GEL Isotretinoin 0.05% w/w

Hair Loss Treatment Regular Strength (Minoxidil)

SIGMACORT cream and ointment

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Dalacin V Cream Clindamycin phosphate

Nail Fungus Guide Symptoms, Treatment and Prevention

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM EMOLLIENT. Light Liquid Paraffin Emollient

CONSUMER MEDICINE INFORMATION

A guide for patients who have been prescribed Stelara

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

WOMEN'S Regaine EXTRA STRENGTH

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Diabetes and Foot Problems

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

Patient Information Leaflet. Dermal Filler

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

v MM 130.2MM FOR WOME N O N C E A D AY

MyStelara. For patients who have been prescribed Stelara

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Caring for your Toenails

Information PROPECIA Finasteride 1mg Tablet

The Kansas Foot Center LASER TREATMENT

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

Daivobet 50/500 gel Dye-vo-bet

WHERE HEALING HAPPENS TWO-STEP HOSPITAL-GRADE SYSTEM RADIATION SKIN CARE

Professional Manicure & Pedicure Kit

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory DERMOCALM LOTION. Calamine and Light Liquid Paraffin Lotion

INSTANT RELIEF! How to cure athlete s foot in seconds

Frequently asked questions about. Scabies. From the Branch-Hillsdale-St. Joseph Community Health Agency

How to cure toenail fungus dr oz

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL HYDROPHASE. Benzoyl Peroxide Cream IP

EUMOVATE Clobetasone butyrate 0.05% w/w cream

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BREVOXYL CREAMY WASH. Benzoyl Peroxide Creamy Wash 4%

How to cure toenail fungus dr oz

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

HOW TO USE. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment

Administering ORENCIA (abatacept): Your Step-by-Step Guide

please complete the following:

Prior to Toenail Surgery Information Sheet

Instructions For Use

POP ACRYLIC NAILS. user guide

A beautiful foot is a great gift of Nature

Transcription:

Medicinal product name Outline PACKAGE LEAFLET: INFORMATION FOR THE USER CURANAIL 5%, medicated nail lacquer Amorolfine Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Keep this leaflet, you may need to read it again. Ask your pharmacist, if you need more information or advice. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if your symptoms worsen or do not improve within 3 months. Leaflet contents What is in this leaflet: 1. WHAT CURANAIL 5%, medicated nail lacquer IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU USE CURANAIL 5%, medicated nail lacquer 3. HOW TO USE CURANAIL 5%, medicated nail lacquer 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE CURANAIL 5%, medicated nail lacquer 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT CURANAIL 5%, medicated nail lacquer IS AND WHAT IT IS USED FOR Invented name, active substance and pharmacotherapeutic group CURANAIL 5% is an antifungal medicated nail lacquer (medicine for treatment of infections caused by a microscopic fungus). Therapeutic indications CURANAIL 5% is used to treat nail mycoses (infections caused by a fungus) affecting up to 2 nails in adults. A mycosis generally results in nail discolouration (white, yellow or brown) and thickening, although the appearance may vary considerably. If the infection is limited to the upper part of the nail as in photo nb1 below, follow the advice of your pharmacist. If the infection appears to be more like photos nb 2 or 3, you should see your doctor. 2. What you need to know before you use CURANAIL 5%, medicated nail lacquer Contra-indications Do not use CURANAIL:

o o if you are allergic (hypersensitive) to the active ingredient (amorolfine) or to one of the other ingredients of CURANAIL, if you are under 18 years old. Appropriate precautions for use: specific warnings Warnings and precautions: Avoid all contact with your eyes, ears or mucous membranes. You must consult your physician: o If you suffer from diabetes, o if you are being treated for an immune system disorder (disorder that reduces the body s defenses), o if you have poor blood circulation in your hands and feet, o if you have a history of nail injury, skin condition such as psoriasis, other chronic skin conditions, swelling, yellow nails combined with breathing disorders, painful nails, distorted/deformed nails or any other disorder around your nail. o if your nail is severely damaged (over two thirds of the nail plate is affected) or infected. In these cases, your doctor may prescribe oral therapy as well as your medicated nail lacquer. During the application of amorolfine no cosmetic nail lacquer or artificial nails shall be used. When organic solvents are used impermeable gloves shall be used otherwise amorolfine nail lacquer will be removed. This product contains ethanol (alcohol). Using the product too often or applying inappropriately can cause irritation or dryness of the surrounding skin. Interactions with other medicines Other medicines and CURANAIL: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Interactions with food or drink Use by pregnant or breast-feeding women, information on fertility Pregnancy, breast-feeding and fertility Experience with amorolfine use during pregnancy and/or lactation is limited. Amorolfine should not be used during pregnancy and/or lactation unless clearly necessary. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Effects on the ability to drive or to use machines Excipients warnings 3. HOW TO USE CURANAIL 5%, medicated nail lacquer? Instructions for proper use Before starting treatment Shade the nail surface affected by the infection on the diagram below. This will help you to remember how the nail originally looked when the efficacy of your treatment is reviewed. Every 3

months, shade the affected area until the infected nail has grown out completely. If two nails are infected, select the most infected nail. Take this leaflet with you when you ask for the advice of your doctor or pharmacist. Before treatment 1 month 2 months 3 months 6 months Dosage, administration methods and/or routes, administration rate and length of treatment Posology NAILS SHOULD BE TREATED ONCE A WEEK. This treatment must be continued until the healthy nail has grown back, that is about 6 months for fingernails and 9 to 12 months for toenails. Nails grow slowly, so it may take 2 to 3 months before an improvement is seen. It is important to continue using the lacquer until the infection has cleared and the healthy nail has grown back. However, if there is no improvement after 3 months, you must consult your doctor. Method of administration The following steps must be strictly followed for each nail. Step 1: prepare the nail Remove any former nail varnish with a nail varnish remover. With a new nail file, file the whole surface of the nail, especially the infected areas. CAUTION: do not use the same nail file for healthy nails to avoid spreading the infection. Take care that no one else uses your files. Step 2: clean the nail Use one of the cleansing swabs provided in the pack to clean your nail. Keep the swab as you will need it later for cleaning the applicator. Step 3: treat the nail Dip one of the re-usable applicators into the bottle of lacquer. The lacquer must not be wiped off on the edge of the bottle. Apply the lacquer evenly over the whole surface of the nail. Let it dry for about 3 minutes. Repeat the above procedures for each infected nail. Before using the bottle next time, remove any remaining lacquer layers and file your nail again. Clean your nail with the cleansing swab and apply the lacquer once more as indicated above.

After each application of CURANAIL: The applicator must be carefully cleaned using the swab. An applicator may be used several times, if thoroughly cleaned after each application to avoid contaminating other nails. Use the same swab that you used for cleaning your nail. Do not touch treated nails with the swab. Remove any lacquer which may be on the exterior of the stopper with one of the swabs provided. Close the bottle tightly. Dispose of the swab carefully as it is inflammable. Wash your hands carefully. However, when applying the lacquer to your fingernails, wait until it has completely dried before washing. Warning Do not wear artificial nails during the whole treatment period. Wait until the lacquer is dry before washing your hands or feet. When the lacquer is dry, it is resistant to soap and water: you can therefore wash your hands and feet as usual. Duration of treatment It is important to carry on using the nail lacquer until the infection has cleared and a healthy nail has grown back. This takes about 6 months for fingernails and 9 to 12 months for toenails. You will see a healthy nail growing as the infected nail grows out. Before treatment After treatment If there are no signs of improvement after 3 months of treatment, you should see your doctor. IMPORTANT If you get CURANAIL, 5% in your eyes or ears, wash it out with water immediately and contact your doctor, your pharmacist or your nearest hospital straight away. Avoid the lacquer coming into contact with mucous membranes (e.g. mouth or nostrils). Do not inhale the lacquer. If you, or anyone else, accidentally swallow the lacquer, contact your doctor, your pharmacist or your nearest hospital straight away. Symptoms and instructions in the case of an overdose Instructions if one or more doses have been missed

Withdrawal syndrome risk 4. POSSIBLE SIDE EFFECTS Description of side effects Like all medicines, CURANAIL 5%, medicated nail lacquer can have side effects, although not everybody gets them. Reactions to the medication are rare. Some nail abnormalities (nail discolouration, fragile or brittle nails), skin burning sensations, redness, itching, hives, blisters and allergic skin reactions have been reported. However, these abnormalities could be directly related to the nail infection. Rare: may affect up to 1 in 1,000 people Nail damages, nail discoloration, fragile or brittle nails. Very rare: may affect up to 1 in 10,000 people Skin burning sensation. Not known: frequency cannot be estimated from the available data Redness, itching, hives, blister, allergic skin reaction Reporting of side effects: If you notice any side effects not listed in this leaflet or if any of the side effects gets serious, please tell your doctor or pharmacist. You can also report side effects directly directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine. France Agence nationale de sécurité du médicament et des produits de santé (Ansm) et réseau des Centres Régionaux de Pharmacovigilance Site internet: www.ansm.sante.fr Italia Agenzia Italiana del Farmaco Sito web: http://www.agenziafarmaco.gov.it/it/responsabili Ireland Pharmacovigilance Section Irish Medicines Board Kevin O Malley House Earlsfort Centre Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.imb.ie e-mail: imbpharmacovigilance@imb.ie 5. HOW TO STORE CURANAIL 5%, medicated nail lacquer. Keep this medicine out of the sight and reach of children.

Expiry date Do not use CURANAIL 5%, medicated nail lacquer after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month. Storage conditions Keep this medicine away from heat. Close the bottle tightly after use. If necessary warning concerning visible signs of deterioration Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION Complete list of active ingredients and excipients What CURANAIL contains: The active substance is: Curanail medicated nail lacquer contains 50 mg/ml (5% w/v) of the active substance amorolfine (as amorolfine hydrochloride) The other ingredients are: methacrylic acid copolymer (EUDRAGIT RL100), triacetin, butyl acetate, ethyl acetate and ethanol anhydrous. Pharmaceutical form and contents What CURANAIL looks like and contents of the pack This medicine consists of 1 bottle filled with 2.5 ml of medicated nail lacquer together with applicators, cleansing swabs and nail files. Name and address of the marketing authorisation holder and the manufacturing authorisation holder responsible for releasing batches if they are not the same companies Marketing Autorisation Holder Galderma (UK) Ltd Meridien House 69-71 Clarendon Road Watford Herts WD17 1DS UK Manufacturer LABORATOIRES GALDERMA ZI - MONTDESIR 74540 ALBY-SUR-CHERAN FRANCE Proprietary names in the European Economic Area FRANCE: CURANAIL IRELAND: CURANAIL ITALY: ONILAQ Leaflet approval date

This leaflet was last approved in {MM/YYYY}. MA under exceptional circumstances Web information Detailed information on this medicine is available on the Afssaps (France) website. Information for health professionals only Other ADVICE AND RECOMMENDATIONS TO SUPPORT YOUR TREATMENT Nail mycoses (onychomycosis): what are the risk factors? Toe nails: repetitive minor nail or foot trauma, the toes being wrongly positioned wearing closed shoes and/or plastic shoes or synthetic fibre socks, all of which encourage dampness. professions where boots or safety shoes are necessary, as this can encourage perspiration. sports resulting in impact to the feet such as judo or running and barefoot sports such as swimming. Finger nails: Check for a fungal foot infection (known as dermatophytosis). Repeated contacts with water (which can induce a type of mycosis known as candidiasis). Nail trauma or irritation through: o repetitive minor traumas (gardening ), o manual use of detergents (washing powders and liquids or other harsh products), o occupational exposure (hairdressers, manicurists, podiatrists). Nail mycoses (onychomycosis): how to prevent and avoid contamination? Disinfect shoes and socks. Ask your pharmacist for advice if necessary. Treat all skin infections between the toes and of the feet (on the sole) as soon as possible. Use your own towel to avoid contaminating other people. Dry the spaces between your toes and the whole surface of your feet carefully, after you shower or bath, to avoid contaminating the other nails and the skin. Nail mycoses (onychomycosis): why is it important to follow the treatment carefully? For it to be effective, the treatment must be applied during the whole period scheduled, without interruption, until your nail has grown out completely. DO NOT BE DISCOURAGED! The treatment may take 6 months for fingernails and 9 to 12 months for toenails. All treatments are long: to be effective the treatment must be continued until the nail has grown out completely. For any other information concerning onychomycosis: